HQ

Active Director Director DIN 08276932
DIN 08276932 First appointment Nov 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value •••• Premium profile

About He Qiang

Data last updated:

He Qiang is a Director at Heyer Medical India Private Limited (since 2018). The company operates in Healthcare. Heyer Medical India Private Limited reported revenue of ₹2.79 Cr (FY 2025).

DIN 08276932
Primary Designation Director
Industry Healthcare
First Appointment 12 Nov 2018
Oldest Company Age 7 yrs
Largest company Heyer Medical India Private Limited · ₹2.79 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Heyer Medical India Private Limited U33110KA2018PTC183539
Director12 Nov 20182018₹2.79 Cr (FY 2025)Active

Board colleagues of He Qiang

Directorship timeline

Open interactive timeline →
Heyer Medical India Private Limited
Premium access

Shareholding and investment profile for He Qiang

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about He Qiang

He Qiang currently holds 1 directorship: Heyer Medical India Private Limited (Director, since 12 Nov 2018, revenue ₹2.79 Cr (FY 2025)).

He Qiang was first appointed on 12 Nov 2018 as Director at Heyer Medical India Private Limited.

The current boards of He Qiang's companies include Ajaykrishnan Menon (Heyer Medical India Private Limited), Changying Li (Heyer Medical India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available